EAM GLOBAL INVESTORS LLC – Revance Therapeutics, Inc. Transaction History
EAM GLOBAL INVESTORS LLC portfolio value:
$1.70M
portfolio value
Revance Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | 0.00% | 63.27K shares | 1.70M | $27 | 63.27K |
| Q3 2020 | share | Decrease | -100.00% | -40.54K shares | -990K | $25.14 | 0 |
| Q2 2020 | share | Decrease | -63.12% | -69.39K shares | -637K | $24.42 | 40.54K |
| Q1 2020 | share | Decrease | -19.42% | -26.50K shares | -587K | $14.8 | 109.93K |
| Q4 2019 | share | Increase | 0.00% | 136.44K shares | 2.21M | $16.23 | 136.44K |
| Q2 2018 | share | Decrease | -100.00% | -44.89K shares | -1.38M | $27.45 | 0 |
| Q1 2018 | share | 0.00% | 0 shares | -222K | $30.8 | 44.89K | |
| Q4 2017 | share | Increase | 0.00% | 44.89K shares | 1.60M | $35.75 | 44.89K |